Factors influencing poor response to type 2 targeted therapies in severe asthma: a retrospective cohort study
A significant breakthrough has been made in treating severe asthma, with the recognition of various asthma phenotypes and an updated management guideline. Type 2 targeted therapies, such as benralizumab and om...